What is Edwards Lifesciences's total revenue?

Edwards Lifesciences (EW) reported total revenue of $1.65B in Q1 2026.

How has Edwards Lifesciences's total revenue changed year-over-year?

Edwards Lifesciences's total revenue increased by 16.7% year-over-year, from $1.41B to $1.65B.

What is the long-term trend for Edwards Lifesciences's total revenue?

Over 4 years (2021 to 2025), Edwards Lifesciences's total revenue has grown at a 3.8% compound annual growth rate (CAGR), from $5.23B to $6.07B.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Edwards Lifesciences EW Total Revenue

Total Revenue at other companies

Cabot CorporationCBT

$904M-3.4%

UnifirstUNF

$622.51M+3.4%

HES

Hess MidstreamHESM

$390.1M+2.1%

BeldenBDC

$696.38M+11.4%

MYR GroupMYRG

$1B+20.0%

Helen Of TroyHELE

$470.03M-3.3%

Segments

By segment

See full

United States$937.6M+11.8%

Europe$442.6M+29.5%

Rest of World$177.8M+18.4%

Japan$90.6M+10.8%

By product

See full

Transcatheter Aortic Valve Replacement$1.2B+14.4%

Surgical$276.2M—

Transcatheter Mitral and Tricuspid Therapies$175.1M+52.0%

Other financials

Income statement

See full

Gross profit$1.3B+15.7%

Operating income$477.6M+21.0%

Net income$380.7M+6.3%

EPS (diluted)$0.66+8.2%

Balance sheet

See full

Cash & equivalents$2.4B-22.3%

Total debt$702.9M+0.5%

Total equity$10.3B+2.0%

Total assets$13.3B+2.3%

Cash flow

See full

Operating cash flow$43.8M-84.4%

CapEx$64.9M+15.9%

Free cash flow-$21.1M-109%

Valuation

See full

Market cap$51.66B+19.3%

Enterprise value$49.92B+22.2%

P/E47.1×+36.8×

P/S8.2×+0.4×

Profitability

See full

Gross margin77.9%-1.6pp

Operating margin21.4%-4.4pp

Net margin17.4%-58.3pp

FCF margin17.3%—

Returns & leverage

See full

Return on equity10.7%-37.8pp

Debt / equity0.1×0.0×

Current ratio4.4×0.0×

Where this comes from

Reported directly by Edwards Lifesciences in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Edwards Lifesciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Edwards Lifesciences's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Edwards Lifesciences's total revenue?: Edwards Lifesciences (EW) reported total revenue of $1.65B in Q1 2026.
How has Edwards Lifesciences's total revenue changed year-over-year?: Edwards Lifesciences's total revenue increased by 16.7% year-over-year, from $1.41B to $1.65B.
What is the long-term trend for Edwards Lifesciences's total revenue?: Over 4 years (2021 to 2025), Edwards Lifesciences's total revenue has grown at a 3.8% compound annual growth rate (CAGR), from $5.23B to $6.07B.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.